Advaxis, Inc. (ADXS)
ADXS moved a median of 0.00% 30 minutes after news, and -1.24% by the close. How ADXS actually reacts to news — the realized, point-in-time move the market made, measured across 48 labeled events over the last three years with zero look-ahead.
ADXS’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 14% | 42 |
| 30-min | 0.00% | 21% | 47 |
| 60-min | 0.00% | 21% | 47 |
| to close | -1.24% | 32% | 47 |
| Middle 50% of ADXS reactions | -10.50% to 0.00% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 48 |
Half of all Advaxis, Inc. news events land between -10.50% and +0.00% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when ADXS moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ADXS's baseline. Nothing else.
Recent ADXS events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Ayala Pharmaceuticals Files Form 15 to Voluntarily Deregister and Suspend its Reporting Obligations | Press release | GlobeNewswire | -3.85% | -15.96% | |
| Form 15-12G Ayala Pharmaceuticals, | SEC filing · Form 15-12G | SEC EDGAR | -3.85% | -15.96% | |
| Form 10-K/A Ayala Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | +19.82% | |
| Form 8-K/A Ayala Pharmaceuticals, For: Mar 25 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -4.67% | |
| Form 10-K Ayala Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | -0.69% | |
| Form S-8 POS Ayala Pharmaceuticals, | SEC filing · Form S-8 | SEC EDGAR | -12.05% | -12.21% | |
| Form 8-K Ayala Pharmaceuticals, For: Mar 25 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -9.40% | |
| Form NT 10-K Ayala Pharmaceuticals, For: Apr 01 | SEC filing · Form NT | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K Ayala Pharmaceuticals, For: Mar 25 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K Ayala Pharmaceuticals, For: Mar 01 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -6.13% | |
| Form DEFM14C Ayala Pharmaceuticals, | SEC filing · Form DEFM14C | SEC EDGAR | +6.25% | -4.47% | |
| Form 8-K Ayala Pharmaceuticals, For: Feb 20 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +2.11% | |
| Form PREM14C Ayala Pharmaceuticals, For: Feb 20 | SEC filing · Form PREM14C | SEC EDGAR | +0.00% | +21.76% | |
| Form 8-K Ayala Pharmaceuticals, For: Feb 07 | SEC filing · Form 8-K | SEC EDGAR | -13.33% | -12.38% | |
| Form 8-K Ayala Pharmaceuticals, For: Feb 05 | SEC filing · Form 8-K | SEC EDGAR | +30.82% | +41.64% | |
| Form 8-K/A Ayala Pharmaceuticals, For: Oct 18 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -3.66% | |
| Form 10-Q Ayala Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.00% | |
| Form NT 10-Q Ayala Pharmaceuticals, For: Nov 14 | SEC filing · Form NT | SEC EDGAR | +0.00% | -1.24% | |
| Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors | Press release | GlobeNewswire | +0.00% | -10.53% | |
| Form D Ayala Pharmaceuticals, | SEC filing · Form D | SEC EDGAR | +0.00% | +5.01% | |
| Ayala Pharmaceuticals Presents Updated AL102 Results from Phase 2 Clinical Trial in Desmoid Tumors at ESMO Congress 2023 | Press release | GlobeNewswire | +5.56% | +0.00% | |
| Form 8-K Ayala Pharmaceuticals, For: Oct 18 | SEC filing · Form 8-K | SEC EDGAR | +5.56% | +0.00% | |
| Ayala Pharmaceuticals Announces Closing of Merger with Biosight | Press release | GlobeNewswire | +0.00% | +0.00% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ADXS section they belong to.
Where else ADXS is measured.
ADXS earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Horizon Therapeutics Public Limited Company - Ordinary Shares (HZNP) | 49 | -0.01% | 17% |
| Valion Bio, Inc. (VBIO) | 49 | 0.00% | 49% |
| Arch Biopartners Inc (ARCH_CDNX) | 48 | -0.59% | 19% |
| SINO BIOPHARM ORD (SBMFF) | 48 | 0.00% | 4% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Advaxis, Inc.'s median reaction calculated?
Every labeled ADXS news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 48 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 21% of ADXS's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does ADXS's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.